Early research (Phase 1)Study completedNCT03042793What this trial is testingVaccination With PD-L1 Peptide Against Multiple MyelomaWho this might be right forMultiple Myeloma Lene Meldgaard Knudsen 10
Early research (Phase 1)Study completedNCT00938626What this trial is testingTreated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Barbara Ann Karmanos Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT00004158What this trial is testingRadiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Early research (Phase 1)Looking for participantsNCT06042725What this trial is testingMC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple MyelomaWho this might be right forMultiple Myeloma Mayo Clinic 100
Not applicableStudy completedNCT00898040What this trial is testingStudy of DNA Samples From Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm ECOG-ACRIN Cancer Research Group 600
Early research (Phase 1)Study completedNCT01995708What this trial is testingCT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationWho this might be right forMultiple Myeloma Memorial Sloan Kettering Cancer Center 28
Early research (Phase 1)Study completedNCT00310024What this trial is testingVorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRefractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00616720What this trial is testingInterferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03104842What this trial is testingEvaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and DexamethasoneWho this might be right forMultiple Myeloma Universitätsklinikum Hamburg-Eppendorf 246
Early research (Phase 1)UnknownNCT05363800What this trial is testingPhase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple MyelomaWho this might be right forRecurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma Jiangsu HengRui Medicine Co., Ltd. 198
Testing effectiveness (Phase 2)Ended earlyNCT00003511What this trial is testingAntineoplaston Therapy in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Burzynski Research Institute 5
Large-scale testing (Phase 3)Study completedNCT00064038What this trial is testingS0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple MyelomaWho this might be right forMultiple MyelomaPlasma Cell Neoplasm SWOG Cancer Research Network 198
Testing effectiveness (Phase 2)Study completedNCT03773107What this trial is testingLCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Wake Forest University Health Sciences 12
Testing effectiveness (Phase 2)Study completedNCT01212952What this trial is testingPomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRefractory Multiple Myeloma Mayo Clinic 50
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30
Early research (Phase 1)UnknownNCT03767725What this trial is testingAnti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple MyelomaWho this might be right forMultiple Myeloma in Relapse Shenzhen Second People's Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04126200What this trial is testingPlatform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma GlaxoSmithKline 208